Immunological Assessment of Key Biomarkers in Stage III Breast Cancer

Abstract

Objective: To investigate the predictive role of some immune parameters in progressive and diagnostic of stage III breast cancer BC patient. Methods: The study was conducted at Specialized Oncology Center – Tikrit City, and the Oncology of Baghdad Teaching Hospital, Baghdad city, Iraq, on 80 blood samples, 50 samples from women with stage III breast cancer, and 30 samples for control group (healthy women), the age range (25–50) year. The collect serum assessed by ELIZA, and the data analyzed by Independent-Samples T test spss. While AUC is measured by MedCalc. Results: Serum levels of all parameters were dramatically higher in patients group compared to control except in IL-23 which exhibitedslight elevation statically not significant. The (AUC) for the associated ROC curve of CA15-3 (1), TGF-β (1) and IL-10 (1) were the largest.AUC is valuable diagnostic parameters to predict of progressive and diagnostic of the disease, followed by TNF-α (0.997), IL-6 (0.974), IL-17 (0.890), IL-8 (0.838), CTL-4 (0.819) and finally the lowest on was IL-23 (0.616). Conclusion: Increasing levels of the measured parameters are an essential predictor of progressive and diagnostic of the disease.